Federico Grossi - 01 Dec 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Issuer symbol
APLS
Transactions as of
01 Dec 2021
Net transactions value
-$15,900
Form type
4
Filing time
03 Dec 2021, 15:00:57 UTC
Previous filing
17 Nov 2021
Next filing
09 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $15,900 -375 -0.58% $42.40 64,104 01 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.